Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05923606 · ClinicalTrials.gov registry record · NA

Modulation of Brain Oscillations Underlying Working Memory

A NA study of Working Memory, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05923606: Recruiting NA study of Working Memory, sponsored by Massachusetts General Hospital.

NCT05923606 is a NA study of Working Memory that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 32 participants, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05923606, a NA study of Working Memory, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric currents passed through electrodes on the scalp.

Primary Outcome

Accuracy of working memory retrieval during a Delayed Match-to-Sample task will be assessed before and during tACS interventions

Conditions Studied

Interventions

  • DEVICE Active tACS
  • DEVICE Placebo tACS

Study Locations (1)

Massachusetts

  • Martinos Center for Biomedical Imaging - Charlestown

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-07-10
Est. Completion 2027-03-31
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT05923606 shows while recruiting

NCT05923606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (48% lower).

The record links to 1 condition, with Working Memory appearing as the primary indexed condition, and to 2 interventions - of which Active tACS is the first listed.

NCT05923606 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05923606 about?

NCT05923606 is a clinical study titled "Modulation of Brain Oscillations Underlying Working Memory". This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric c...

What is the current status of trial NCT05923606?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-07-10. Estimated completion is 2027-03-31.

What conditions does trial NCT05923606 study?

This clinical trial studies the following conditions: Working Memory.

What interventions are being tested in trial NCT05923606?

The interventions under investigation include: Active tACS (DEVICE), Placebo tACS (DEVICE).

Who is sponsoring clinical trial NCT05923606?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05923606 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Working Memory

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05923606, the US trial registry maintained by the National Library of Medicine. NCT05923606 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.